ZA98420B - Use of pramipexole in the treatment of restless legs syndrome. - Google Patents

Use of pramipexole in the treatment of restless legs syndrome.

Info

Publication number
ZA98420B
ZA98420B ZA9800420A ZA98420A ZA98420B ZA 98420 B ZA98420 B ZA 98420B ZA 9800420 A ZA9800420 A ZA 9800420A ZA 98420 A ZA98420 A ZA 98420A ZA 98420 B ZA98420 B ZA 98420B
Authority
ZA
South Africa
Prior art keywords
pramipexole
treatment
restless legs
legs syndrome
syndrome
Prior art date
Application number
ZA9800420A
Other languages
English (en)
Inventor
Wolfgang H Oertel
Dieter Meier
Baltazar Gomez-Mancilla
Jacques Montplaisir
Original Assignee
Upjohn Co
Boehringer Ingelheim Pharma
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Upjohn Co, Boehringer Ingelheim Pharma filed Critical Upjohn Co
Publication of ZA98420B publication Critical patent/ZA98420B/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/425—Thiazoles
    • A61K31/428—Thiazoles condensed with carbocyclic rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/425—Thiazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P21/00—Drugs for disorders of the muscular or neuromuscular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/20—Hypnotics; Sedatives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Neurosurgery (AREA)
  • Epidemiology (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Psychology (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Anesthesiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Thiazole And Isothizaole Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Orthopedics, Nursing, And Contraception (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Corsets Or Brassieres (AREA)
  • Semiconductor Memories (AREA)
  • Liquid Crystal Substances (AREA)
ZA9800420A 1997-01-17 1998-01-19 Use of pramipexole in the treatment of restless legs syndrome. ZA98420B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE19701619A DE19701619B4 (de) 1997-01-17 1997-01-17 Verwendung von Pramipexol zur Behandlung des restless legs syndroms

Publications (1)

Publication Number Publication Date
ZA98420B true ZA98420B (en) 1999-07-19

Family

ID=7817708

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA9800420A ZA98420B (en) 1997-01-17 1998-01-19 Use of pramipexole in the treatment of restless legs syndrome.

Country Status (24)

Country Link
EP (1) EP0989850B1 (hu)
JP (2) JP4406685B2 (hu)
KR (2) KR100761774B1 (hu)
CN (1) CN1117564C (hu)
AT (1) ATE281165T1 (hu)
AU (1) AU723119B2 (hu)
BG (1) BG64614B1 (hu)
CA (1) CA2275379C (hu)
CZ (1) CZ289863B6 (hu)
DE (2) DE19701619B4 (hu)
ES (1) ES2231959T3 (hu)
FI (1) FI120135B (hu)
HK (1) HK1024408A1 (hu)
HU (1) HU226564B1 (hu)
NO (1) NO321151B1 (hu)
NZ (2) NZ336804A (hu)
PL (1) PL190898B1 (hu)
PT (1) PT989850E (hu)
RO (1) RO120757B1 (hu)
RU (1) RU2192252C2 (hu)
SI (1) SI20060A (hu)
SK (1) SK284264B6 (hu)
WO (1) WO1998031362A1 (hu)
ZA (1) ZA98420B (hu)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6001861A (en) 1998-01-16 1999-12-14 Pharmacia & Upjohn Company Use of pramipexole in the treatment of restless legs syndrome
DE19701619B4 (de) * 1997-01-17 2007-10-11 Boehringer Ingelheim Pharma Gmbh & Co. Kg Verwendung von Pramipexol zur Behandlung des restless legs syndroms
SE9803760D0 (sv) * 1998-11-04 1998-11-04 Jan Hedner Sätt att behandla och diagnostisera syndromet restless legs och motsvarande medel
DE19938825A1 (de) * 1999-08-19 2001-04-26 Boehringer Ingelheim Pharma Wirkstoffkombination mit Clonidin
DE10220230A1 (de) * 2002-05-06 2003-11-27 Sanol Arznei Schwarz Gmbh Verwendung von Rotigotine zur Behandlung des Restless Leg Syndroms
EP1940398A1 (de) * 2005-10-18 2008-07-09 Boehringer Ingelheim International GmbH Verwendung von pramipexol zur behandlung des moderaten bis schweren restless legs syndroms (rls)
JP5769923B2 (ja) * 2006-04-03 2015-08-26 テバ ファーマシューティカル インダストリーズ リミティド レストレスレッグス症候群の治療のためのラサギリンの使用
TR200906997A1 (tr) 2009-09-11 2011-03-21 Sanovel �La� San. Ve T�C. A. �. Pramipeksol farmasötik bileşimleri.
TR200907554A1 (tr) 2009-10-06 2011-04-21 Sanovel İlaç San.Ve Ti̇c.A.Ş. Oral yolla dağılan pramıpexole bileşimleri.

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3572485D1 (en) * 1984-12-22 1989-09-28 Thomae Gmbh Dr K Tetrahydro-benzothiazoles, their production and their use as intermediates or drugs
DE3843227A1 (de) * 1988-12-22 1990-07-05 Boehringer Ingelheim Kg Neue verwendung von 2-amino-6-n-propylamino-4,5,6,7-tetrahydrobenzthiazol
DE3933738A1 (de) * 1989-10-10 1991-04-11 Boehringer Ingelheim Kg Neue verwendung von 2-aminothiazol-derivaten (tsh)
DE3937271A1 (de) * 1989-11-09 1991-05-16 Boehringer Ingelheim Kg Transdermale applikation von 2-amino-6-n-propylamino-4,5,6,7-tetrahydrobenzothiazol
DE4125446A1 (de) * 1991-08-01 1993-02-04 Uwe Dipl Ing Behmann Verfahren und einrichtung zur elektrischen kurzschlusspruefung und -ortung fuer leitungen, insbesondere fuer fahrleitungen elektrischer bahnen
US5598352A (en) * 1994-09-30 1997-01-28 Cirrus Logic, Inc. Method and apparatus for audio and video synchronizing in MPEG playback systems
US5650420A (en) * 1994-12-15 1997-07-22 Pharmacia & Upjohn Company Pramipexole as a neuroprotective agent
DE19701619B4 (de) * 1997-01-17 2007-10-11 Boehringer Ingelheim Pharma Gmbh & Co. Kg Verwendung von Pramipexol zur Behandlung des restless legs syndroms

Also Published As

Publication number Publication date
EP0989850B1 (en) 2004-11-03
SK284264B6 (sk) 2004-12-01
JP2009062388A (ja) 2009-03-26
ES2231959T3 (es) 2005-05-16
BG64614B1 (bg) 2005-09-30
DE69827387T2 (de) 2005-10-27
SK92099A3 (en) 2000-08-14
ATE281165T1 (de) 2004-11-15
CZ289863B6 (cs) 2002-04-17
SI20060A (sl) 2000-04-30
JP4406685B2 (ja) 2010-02-03
CA2275379C (en) 2006-11-28
BG103543A (en) 2000-04-28
FI991616A (fi) 1999-07-16
DE19701619A1 (de) 1998-07-23
RU2192252C2 (ru) 2002-11-10
NO993360L (no) 1999-07-07
HK1024408A1 (en) 2000-10-13
CN1243439A (zh) 2000-02-02
HUP0001913A3 (en) 2002-09-30
NZ510007A (en) 2004-11-26
KR20000070234A (ko) 2000-11-25
WO1998031362A1 (en) 1998-07-23
FI120135B (fi) 2009-07-15
HUP0001913A2 (hu) 2000-11-28
AU6016898A (en) 1998-08-07
CN1117564C (zh) 2003-08-13
HU226564B1 (en) 2009-04-28
KR20050085947A (ko) 2005-08-29
DE19701619B4 (de) 2007-10-11
AU723119B2 (en) 2000-08-17
NZ336804A (en) 2001-03-30
DE69827387D1 (de) 2004-12-09
PL190898B1 (pl) 2006-02-28
NO321151B1 (no) 2006-03-27
PT989850E (pt) 2004-12-31
EP0989850A1 (en) 2000-04-05
KR100761774B1 (ko) 2007-10-04
RO120757B1 (ro) 2006-07-28
NO993360D0 (no) 1999-07-07
JP2001511158A (ja) 2001-08-07
PL334498A1 (en) 2000-02-28
CZ247899A3 (cs) 2000-01-12
CA2275379A1 (en) 1998-07-23

Similar Documents

Publication Publication Date Title
ZA200004452B (en) Use of cabergoline in the treatment of restless legs syndrome.
MXPA03003870A (es) Terapia de combinacion que comprende agentes antidiabeticos y anticonvulsionantes.
SI0797439T1 (en) Use of pramipexole as a neuroprotective agent
MX9700538A (es) Uso de droloxifeno y sus sales farmaceuticamente aceptables en la preparacion de remedios para las enfermedades cardiovasculares.
PT755249E (pt) Utilizacao de inibidores da reaccao de maillard para o tratamento de doenca com base em amiloidose
IT1276829B1 (it) Mobili per sedersi
YU15299A (sh) Farmaceutski sastavi
HK1020259A1 (en) Composition for use in the treatment and prevention of hyperuricemia.
ZA975288B (en) The use of TCET in the prophylaxis and treatment of allergies.
HK1024408A1 (en) Use of pramipexole in the treatment of restless legs syndrome
AU3922900A (en) Use of (valeriana) for the treatment of restless leg syndrome and related disorders
MX9700298A (es) Adenovirus que comprende un gen que codifica para una no sintasa.
DE69103919D1 (de) Diaminoverbindungen und Vorstufe dafür.
DE69227515D1 (de) Schaum stabilisierende agentien und bittermacher aus hopfen
IL139144A0 (en) Mycobacterial inhibitors
ZA9711468B (en) New use of comt inhibitors
CA98963S (en) Leg for table
GB9723824D0 (en) Cytostatic agents
IT237515Y1 (it) Lettino trasportabile particolarmente studiato per massaggi e perfisioterapisti
ES1037701Y (es) Sillon con reposapiernas extraible.
ZA972949B (en) An article of furniture.
IT246402Y1 (it) Il materasso del riposo.
IT1294084B1 (it) Divano o poltrona e procedimento per la realizzazione.